BeiGene
BGNE
#963
Rank
A$32.03 B
Marketcap
$282.29
Share price
1.02%
Change (1 day)
8.35%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Stock price history for BeiGene (BGNE)

Highest end of day price: $644.78 AUD on 2021-09-17

Lowest end of day price: $38.35 AUD on 2016-02-12

Stock price history of BeiGene from 2016 to 2024

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$1.59-0.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.46-1.91%๐Ÿ‡บ๐Ÿ‡ธ USA